Fisher Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,062	Closed	-$106K	–	974
2021 Q1	$106K	Sell	15,062 -32,237	-68%	-$216K	﹤0.01%	880
2020 Q4	$227K	Buy	47,299 +410	+0.9%	+$2.07K	﹤0.01%	849
2020 Q3	$273K	Buy	46,889 +11	+0%	+$66	﹤0.01%	758
2020 Q2	$316K	Buy	46,878 +67	+0.1%	+$507	﹤0.01%	718
2020 Q1	$298K	Sell	46,811 -34,278	-42%	-$275K	﹤0.01%	684
2019 Q4	$845K	Sell	81,089 -39,187	-33%	-$285K	﹤0.01%	604
2019 Q3	$473K	Hold	120,276	–	–	﹤0.01%	696
2019 Q2	$1.79M	Buy	120,276 +60,725	+102%	+$1.1M	﹤0.01%	554
2019 Q1	$1.48M	Buy	59,551 +120	+0.2%	+$3.01K	﹤0.01%	554
2018 Q4	$1.07M	Hold	59,431	–	–	﹤0.01%	589
2018 Q3	$1.75M	Buy	59,431 +1,125	+2%	+$43.6K	﹤0.01%	533
2018 Q2	$2.65M	Buy	58,306 +10,345	+22%	+$503K	﹤0.01%	506
2018 Q1	$2.53M	Hold	47,961	–	–	﹤0.01%	505
2017 Q4	$3.26M	Buy	47,961 +21,328	+80%	+$1.49M	﹤0.01%	478
2017 Q3	$2.19M	Buy	+26,633	New	+$2.11M	﹤0.01%	490